Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0BC4Q
|
|||
Former ID |
DIB000857
|
|||
Drug Name |
Lifibrol
|
|||
Synonyms |
K-12148; U-83860; (R)-Lifibrol; (S)-Lifibrol; (S)-Lifibrol methyl ester
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Arteriosclerosis [ICD-11: BD40; ICD-10: I70] | Discontinued in Phase 2 | [1] | |
Company |
Klinge Pharma GmbH
|
|||
Structure |
Download2D MOL |
|||
Formula |
C21H26O4
|
|||
Canonical SMILES |
CC(C)(C)C1=CC=C(C=C1)CCC(COC2=CC=C(C=C2)C(=O)O)O
|
|||
InChI |
1S/C21H26O4/c1-21(2,3)17-9-4-15(5-10-17)6-11-18(22)14-25-19-12-7-16(8-13-19)20(23)24/h4-5,7-10,12-13,18,22H,6,11,14H2,1-3H3,(H,23,24)
|
|||
InChIKey |
LNXBEIZREVRNTF-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 96609-16-4
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000343) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.